Development Level

Tbio 19 | 10,625
Tdark 12 | 7,003
Tchem 1 | 1,890

Disease

ovarian cancer 14 | 8,484
Breast cancer 12 | 3,094
psoriasis 12 | 6,685
lung cancer 10 | 4,466
invasive ductal carcinoma 9 | 2,950
lung adenocarcinoma 9 | 2,713
breast carcinoma 8 | 1,614
ductal carcinoma in situ 8 | 1,745
Cancer 6 | 2,346
Multiple myeloma 5 | 1,327
cystic fibrosis 5 | 1,665
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,289
non-small cell lung cancer 5 | 2,798
non-small cell lung carcinoma 5 | 413
osteosarcoma 5 | 7,933
pancreatic cancer 5 | 2,300
atypical teratoid / rhabdoid tumor 4 | 4,369
cutaneous lupus erythematosus 4 | 1,056
glioblastoma 4 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
malignant mesothelioma 4 | 3,162
subependymal giant cell astrocytoma 4 | 2,287
Cleft palate 3 | 125
Connective tissue disease 3 | 59
Dyskeratosis congenita 3 | 24
Leishmaniasis 3 | 49
Lupus erythematosus 3 | 80
Mammary Neoplasms 3 | 410
colon cancer 3 | 1,475
group 4 medulloblastoma 3 | 1,875
lung carcinoma 3 | 2,844
pituitary cancer 3 | 1,972
Chronic Lymphocytic Leukemia 2 | 242
Endometriosis 2 | 535
HOYERAAL-HREIDARSSON SYNDROME 2 | 6
Pick disease 2 | 1,893
Thyroiditis 2 | 25
Waldenstrons macroglobulinemia 2 | 765
dermatomyositis 2 | 933
gastric cancer 2 | 430
group 3 medulloblastoma 2 | 2,254
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
nasopharyngeal carcinoma 2 | 1,056
pancreatic carcinoma 2 | 567
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
sonic hedgehog group medulloblastoma 2 | 1,482
spina bifida 2 | 1,064
tuberculosis and treatment for 6 months 2 | 686
ulcerative colitis 2 | 2,087
Adult T-Cell Lymphoma/Leukemia 1 | 30
Anaplastic Oligodendroglioma 1 | 2
Anemia 1 | 252
Ankylosing spondylitis 1 | 138
Aplastic anemia 1 | 18
Ataxia telangiectasia 1 | 31
Atopic dermatitis 1 | 944
Bipolar Disorder 1 | 266
Bone Marrow Diseases 1 | 2
Chromosome Aberrations 1 | 15
Congenital chromosomal disease 1 | 1
Crohn's disease 1 | 304
Down syndrome 1 | 548
Fanconi's anemia 1 | 50
Growth Disorders 1 | 33
Hydronephrosis 1 | 19
IGA Glomerulonephritis 1 | 454
Influenza 1 | 142
Iron metabolism disease 1 | 17
Lymphoid leukemia 1 | 69
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10 1 | 1
Malaria 1 | 140
Male infertility 1 | 170
Melanoma 1 | 261
Neoplasm Recurrence, Local 1 | 23
Nephritis 1 | 29
Nijmegen breakage syndrome 1 | 23
Pneumoconiosis 1 | 14
Primary ciliary dyskinesia 1 | 73
Pulmonary Fibrosis 1 | 66
Seckel syndrome 1 | 34
Skin Neoplasms 1 | 49
Squamous cell carcinoma of esophagus 1 | 82
Testicular cancer 1 | 24
Townes-Brocks syndrome 1 | 15
Type 1 diabetes mellitus 1 | 101
Vaccinia 1 | 37
Werner syndrome 1 | 29
acute myeloid leukemia 1 | 780
adrenocortical carcinoma 1 | 1,427
diabetes mellitus 1 | 1,663
ependymoma 1 | 2,514
gastric carcinoma 1 | 832
hepatocellular carcinoma 1 | 532
inflammatory breast cancer 1 | 404
oligodendroglioma 1 | 2,849
pilocytic astrocytoma 1 | 3,086
posterior fossa group A ependymoma 1 | 1,511
primary pancreatic ductal adenocarcinoma 1 | 1,271
progressive supranuclear palsy 1 | 674
second-degree atrioventricular block 1 | 4

Tissue

Female tissues 32 | 18,647
Male tissues 32 | 17,969
Blood and immune system 31 | 17,995
Cardiovascular System 31 | 17,958
Digestive Tract 31 | 18,473
Endocrine System 31 | 18,512
Nervous System 31 | 18,561
Urinary Tract 31 | 18,444
Liver and Pancreas 30 | 18,136
Respiratory system 30 | 17,484
Skin and soft tissues 24 | 18,115

Target Family

Non-IDG 30 | 11,971
Transcription Factor 2 | 1,400

Reactome Pathway

Packaging Of Telomere Ends 32 | 32
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2B type 1-C/E/F/G/I HIST1H2BC Tbio Non-IDG -1.35785 22.1 103
Histone H2A.V H2AFV Tdark Non-IDG -1.20240 14.0 30
Histone H2B type 1-L HIST1H2BL Tdark Non-IDG 0.36 0.40 42
Histone H2B type 1-N HIST1H2BN Tdark Non-IDG -1.48218 30.2 48
Histone H2A type 1-J HIST1H2AJ Tdark Non-IDG -0.12825 1.19 10
Histone H2B type 1-M HIST1H2BM Tdark Non-IDG 0.16 0.33 20
Histone H2A.J H2AFJ Tdark Non-IDG 0.28 0.61 90
Histone H2A type 1-B/E HIST1H2AB Tbio Non-IDG -1.31612 18.9 109
Protection of telomeres protein 1 POT1 Tbio Non-IDG -1.77005 58.3 169
TERF1-interacting nuclear factor 2 TINF2 Tbio Non-IDG -1.97411 89.8 128